Cyclophilin binding: a receptor-mediated approach to monitoring cyclosporine immunosuppressive activity following organ transplantation.
Lorber
M I
MI
Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06510.
Paul
K
K
Harding
M W
MW
Handschumacher
R E
RE
Marks
W H
WH
D000284:Administration, Oral; D001646:Bile / Q000378:metabolism; D002102:Cadaver; D002352:Carrier Proteins / Q000097:blood*; D003524:Cyclosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000187:drug effects*; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007262:Infusions, Intravenous; D007668:Kidney / Q000187:drug effects; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology*; D008099:Liver / Q000187:drug effects; D008111:Liver Function Tests; D008775:Methylprednisolone / Q000008:administration & dosage; D019696:Peptidylprolyl Isomerase; D011241:Prednisone / Q000008:administration & dosage; D013329:Structure-Activity Relationship
D002352:Carrier Proteins; D003524:Cyclosporins; D019696:Peptidylprolyl Isomerase; D011241:Prednisone; D008775:Methylprednisolone